Medicare AdvantageCoverageHigh impact
Gender Affirmation Surgery - Medicare Advantage (Revised)
Humana·Plastic Surgery, Psychiatry, General Surgery·Medicare Advantage
Effective date
Sep 1, 2026
We identified it
Aug 29, 2026
Summary
Humana Medicare Advantage revised its Gender Affirmation Surgery policy (HUM-1091-004) effective 09/01/2026, establishing specific medical necessity criteria for coverage including documented gender dysphoria diagnosis, one mental health referral letter, and six months of hormone therapy. The policy explicitly excludes cosmetic procedures (facial feminization, voice surgery, body contouring, etc.) but allows coverage for primary gender affirming surgeries (chest, gonadectomy, reconstructive) and hair removal when meeting documented prerequisites. Billing teams must immediately update authorization workflows and claims adjudication rules to align with these coverage determinations.
Action Required
Before 09/01/2026: (1) Billing team must update prior authorization system to require documentation of: persistent DSM-5 gender dysphoria diagnosis, one mental health professional referral letter, and six continuous months of hormone therapy before approving gender affirming surgery claims. (2) Coding team must configure system to automatically deny or route for manual review any claims for excluded procedures (abdominoplasty, blepharoplasty, facial feminization, voice modification, rhinoplasty, thyroid cartilage reduction, etc.). (3) Update claim adjudication rules to flag gender affirming surgical requests for peer review to confirm medical necessity criteria are met per policy. (4) Notify network providers of new documentation requirements—specifically that one referral letter (not multiple) from a licensed mental health professional is required. (5) Create internal reference guide mapping excluded versus covered procedures. Failure to implement these controls will result in claim denials and potential member complaints.